Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Operating Income of $4.55 million for fiscal year 2025.
CHAMPIONS ONCOLOGY, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $4.55M | +161.9% |
| 2024 | -$7.36M | -40.0% |
| 2023 | -$5.26M | -965.9% |
| 2022 | $607.0K | +65.8% |
| 2021 | $366.0K | +119.1% |
| 2020 | -$1.92M | -811.5% |
| 2019 | $270.0K | +119.9% |
| 2018 | -$1.35M | +80.1% |
| 2017 | -$6.81M | +34.0% |
| 2016 | -$10.32M | +22.1% |
| 2015 | -$13.24M | -111.5% |
| 2014 | -$6.26M | -0.6% |
| 2013 | -$6.22M | +31.4% |
| 2012 | -$9.06M | -73.2% |
| 2011 | -$5.24M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$276.0K | -106.1% | -249.2% |
| October 31, 2025 | $185.0K | -74.7% | +135.1% |
| July 31, 2025 | -$527.0K | -139.7% | -111.7% |
| January 31, 2025 | $4.50M | +274.6% | +514.6% |
| October 31, 2024 | $732.0K | +137.4% | -44.9% |
| July 31, 2024 | $1.33M | +152.1% | +151.6% |
| January 31, 2024 | -$2.58M | -4.8% | -31.8% |
| October 31, 2023 | -$1.96M | -28028.6% | +23.4% |
- CHAMPIONS ONCOLOGY, INC. showed an increase of +161.9% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, CHAMPIONS ONCOLOGY, INC.’s operating income has grown by 187.0% (from -$5.24 million to $4.55 million).
- The most recent figure is from CHAMPIONS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: